[1] Torre LA, Bray F, Siegel R, et al.Global cancer statistics, 2012: Global Cancer Statistics, 2012[J]. CA Cancer J Clin,2015,65(2):87-108.
[2] Eto K, Hiki N, Kumagai K, et al.Prophylactic effect of neoadjuvant chemotherapy in gastric cancer patients with postoperative complications[J]. Gastric Cancer,2018,21(4):703-709.
[3] van Hagen P, Hulshof MC, van Lanschot JJ, et al. Preo-perative chemoradiotherapy for esophageal or junctional cancer[J]. N Engl J Med,2012,366(22):2074-2084.
[4] Miller AB, Hoogstraten B, Staquet M, et al.Reporting results of cancer treatment[J]. Cancer,1981,47(1):207-214.
[5] Watanabe H, Okada M, Kaji Y, et al.New response eva-luation criteria in solid tumours: Revised RECIST guideline (version 1.1)[J]. Gan to Kagaku Ryoho,2009, 36(13):2495-2501.
[6] Choi H, Charnsangavej C, Faria SC, et al.Correlation of computed tomography and positron emission tomography in patients with metastatic gastrointestinal stromal tumor treated at a single institution with imatinib mesylate: proposal of new computed tomography response criteria[J]. J Clin Oncol,2007,25(13):1753-1759.
[7] Kurokawa Y, Shibata T, Sasako M, et al.Validity of response assessment criteria in neoadjuvant chemotherapy for gastric cancer(JCOG0507-A)[J]. Gastric Cancer,2014,17(3):514-521.
[8] Liu K, Li G, Fan C, et al.Adapted Choi response criteria for prediction of clinical outcome in locally advanced gastric cancer patients following preoperative chemotherapy[J]. Acta Radiol,2012,53(2):127-134.
[9] Park SR, Lee JS, Chan GK, et al.Endoscopic ultrasound and computed tomography in restaging and predicting prognosis after neoadjuvant chemotherapy in patients with locally advanced gastric cancer[J]. Cancer,2008, 112(11):2368-2376.
[10] Gao X, Zhang Y, Yuan F, et al.Locally advanced gastric cancer: total iodine uptake to predict the response of primary lesion to neoadjuvant chemotherapy[J]. J Cancer Res Clin Oncol,2018,144(11):2207-2218.
[11] Luo Y, Chen J, Huang K, et al.Early evaluation of sunitinib for the treatment of advanced gastroenteropancreatic neuroendocrine neoplasms via CT imaging: RECIST 1.1 or Choi Criteria?[J]. BMC Cancer,2017,17(1):154.
[12] Smith AD, Zhang X, Bryan J, et al.Vascular tumor burden as a new quantitative CT biomarker for predicting metastatic RCC response to antiangiogenic therapy[J]. Radiology,2016,281(2):484-498.
[13] Thian Y, Gutzeit A, Koh DM, et al.Revised Choi ima-ging criteria correlate with clinical outcomes in patients with metastatic renal cell carcinoma treated with sunitinib[J]. Radiology,2014,273(2):452-461.
[14] Rombolà F, Caravetta A, Mollo F, et al.Sorafenib, risk of bleeding and spontaneous rupture of hepatocellular carcinoma. A clinical case[J]. Acta Medica (Hradec Kralove),2011,54(4):177-179.
[15] Di Fabio F, Pinto C, Rojas Llimpe FL, et al.The predictive value of 18F-FDG-PET early evaluation in patients with metastatic gastric adenocarcinoma treated with chemotherapy plus cetuximab[J]. Gastric Cancer,2007, 10(4):221-227.
[16] Mesenas S, Vu C, Mcstay M, et al.A large series, resection controlled study to assess the value of radial EUS in restaging gastroesophageal cancer following neoadjuvant chemotherapy[J]. Dis Esophagus,2010,21(1):37-42.
[17] Yoshikawa T, Tanabe K, Nishikawa K, et al. Accuracy of CT staging of locally advanced gastric cancer after neoadjuvant chemotherapy: cohort evaluation within a randomized phase Ⅱ study[J]. Ann Surg Oncol,2014,21 Suppl 3:S385-S389.
[18] 申屠伟慧, 黄品同, 鄢曹鑫, 等. 超声双重造影在进展期胃癌新辅助化疗疗效评价中的价值[J]. 中华超声影像学杂志,2016,25(3):212-217.
[19] 谭艳娟, 黄品同, 黄安茜, 等. 超声双重造影在进展期胃癌新辅助化疗后T分期及疗效评价中的价值[J]. 中华超声影像学杂志,2012,21(7):587-590.
[20] Kruk-Bachonko J, Krupski W, Czechowski M, et al.Perfusion CT-A novel quantitative and qualitative imaging biomarker in gastric cancer[J]. Eur J Radiol,2017,95:399-408.
[21] Lee SM, Kim SH, Lee JM, et al.Usefulness of CT vo-lumetry for primary gastric lesions in predicting patholo-gic response to neoadjuvant chemotherapy in advanced gastric cancer[J]. Abdom Imaging,2009,34(4):430-440.
[22] Chen XH, Ren K, Liang P, et al.Spectral computed tomography in advanced gastric cancer: Can iodine concentration non-invasively assess angiogenesis?[J]. World J Gastroenterol,2017,23(9):1666-1675.
[23] Tang L, Li ZY, Li ZW, et al.Evaluating the response of gastric carcinomas to neoadjuvant chemotherapy using iodine concentration on spectral CT: a comparison with pathological regression[J]. Clin Radiol,2015,70(11):1198-1204.
[24] 张阳, 张欢, 闫静, 等. 双源双能量CT碘值在评估进展期胃腺癌新辅助化疗疗效中的价值[J]. 诊断学理论与实践,2018,17(2):191-196.
[25] Giganti F, Orsenigo E, Esposito A, et al.Prognostic role of diffusion-weighted MR imaging for resectable gastric cancer[J]. Radiology,2015,276(2):444-452.
[26] Lee DH, Kim SH, Im SA, et al.Multiparametric fully-integrated 18-FDG PET/MRI of advanced gastric cancer for prediction of chemotherapy response: a preliminary study[J]. Eur Radiol,2016,26(8):2771-2778.
[27] Giganti F, De Cobelli F, Canevari C, et al.Response to chemotherapy in gastric adenocarcinoma with diffusion-weighted MRI and (18) F-FDG-PET/CT: correlation of apparent diffusion coefficient and partial volume correc-ted standardized uptake value with histological tumor regression grade[J]. J Magn Reson Imaging,2014,40(5):1147-1157.
[28] Schneider PM, Eshmuminov D, Rordorf T, et al.18FDG-PET-CT identifies histopathological non-responders after neoadjuvant chemotherapy in locally advanced gastric and cardia cancer: cohort study[J]. BMC Cancer,2018, 18(1):548.
[29] Park S, Ha S, Kwon HW, et al.Prospective evaluation of changes in tumor size and tumor metabolism in patients with advanced gastric cancer undergoing chemotherapy: association and clinical implication[J]. J Nucl Med,2017,58(6):899-904.
[30] Smyth E, Schöder H, Strong VE, et al.A prospective eva-luation of the utility of 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography and computed tomography in staging locally advanced gastric cancer[J]. Cancer,2012,118(22):5481-5488.
[31] Chen R, Zhou X, Liu J, et al.Relationship between 18F-FDG PET-CT scans and HER2 expression in gastric cancer[J]. J Nucl Med,2016,57(7):1040-1044.
[32] Lee JW, Jo K, Cho A, et al.Relationship between 18F-FDG uptake on PET and recurrence patterns after curative surgical resection in patients with advanced gastric cancer[J]. J Nucl Med,2015,56(10):1494-1500.
